Organon

Home
Organon

Our mission is to deliver impactful medicines and solutions for a healthier every day. We reserve the right to remove any comments that reference a product.

Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. For more information, visit www.organon.com.

Commenting Guidelines:

Thank you for your interest in Organon. Providing useful and interesting content about our company and fostering open and respectful dialogue around specific topics is our ultimate goal. Organon respects the rights of individuals using social media to voice their views and opinions. However, within our social media channels, we reserve the right to remove comments that are considered inappropriate, off-topic, abusive, or being used to promote and solicit for third-party sites, initiatives or products. We ask that you please respect the following guidelines for our page:

Please refrain from mentioning Organon products or products from other companies. Comments or posts that are factually inaccurate or misleading, are spam, inappropriate, violate another’s copyright or intellectual property, use profanity or are defamatory will be deleted. There may be other circumstances that will require us to remove a comment. Organon reserves the right to delete any posting at its sole discretion. We encourage you to respect fellow community members and follow Facebook's Statements of Rights and Responsibilities. This page is intended to provide a forum for open discussion and the content provided by those other than Organon does not represent the opinions or positions of Organon. The content available on this page is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Organon recommends that you consult your healthcare provider regarding personal health matters. Privacy:

Organon may collect information about you, such as your name and/or user name and the comments you post to understand and address perspectives about our company mission, strategy, practices, developments within our business and in healthcare and for legal and regulatory purposes. For more information about Organon's privacy practices, please read our Privacy Commitment at www.organon.com/privacy.

11/09/2025

August was full of energy and meaningful moments across Organon. From community celebrations to global policy conversations, our teams showed what it means to lead with purpose and impact. Here are some standout highlights:

📍 Organon Asia Pacific recently celebrated 50 years in Pandaan, Indonesia, underscoring a legacy of advancing local healthcare, innovation, and sustainable development. Since its founding in 1975, Pandaan has evolved from a local production facility into a key pharmaceutical hub for the Asia Pacific region, supplying medicines for cardiovascular, respiratory, and pain management.

📍 Organon Northwest Europe welcomed our Head of Manufacturing, Joseph Morrissey, and General Counsel, Kirke Weaver, at our Oss Biotech Production site. During their visit, they toured the new facilities to understand operations and even helped bring our newest mural to life. These murals reflect our purpose, our vision, and the women we support—while celebrating all the founders who see passion and collaborate to drive our mission every day.

📍 Organon Korea shared key insights on women’s health and demographic resilience at the APEC - Asia-Pacific Economic Cooperation Korea 2025. Dr. Monica He, Head of U.S. and Trade Policy, discussed the need for greater investment in fertility care to address declining birth rates. Organon also contributed expertise at two workshops on fertility innovation and labor shortages, reinforcing our role as a trusted partner in shaping demographic policy dialogues.

📍 Organon Canada During Montréal Pride’s Community Days, Organon Canada supported the Quebec Breast Cancer Foundation to raise awareness about breast cancer. Their efforts highlighted the importance of early detection for everyone, including members of the LGBTQ+ community.

🌎

09/09/2025

The start of the college academic year can be a time of reflection and planning—not just for academics, but for reproductive and sexual health too.

For some young women, long-acting reversible contraception (LARCs) may be a birth control option that aligns with their reproductive goals.

Making time to explore your options with a healthcare professional now can help support the future you’re working toward.

04/09/2025

Welcome back to The Birds & The Mes with Dr. Christine Greves, a board certified OB/GYN. In honor of , she’s helping us expand our understanding of what sexual health is because it can include more than what we may have learned in health class. This also means knowing about different birth control options, including barrier methods, long-acting reversible birth control, and short-acting birth control.

28/08/2025

Back-to-school season brings new beginnings and new challenges for families managing atopic dermatitis (AD) in young children.

This chronic inflammatory skin condition affects over 9 million children in the U.S., causing itchy, dry, and inflamed skin that may disrupt sleep, self-esteem and daily routines.

For parents and caregivers, back-to-school prep goes far beyond school supplies. It can involve revisiting treatment options with a doctor, setting treatment schedules, understanding and navigating triggers, and communicating with teachers about a child's unique needs.

At Organon, we’re committed to providing treatment options to help children and their families manage AD at home, in the classroom, and beyond.

25/08/2025

Things Dr. Greves, a board certified OB/GYN, wishes more women knew? Bone health is a part of women’s health and bone loss may start sooner than expected. If an OB/GYN is the only doctor you typically see regularly, they’ll be a key partner in helping protect bone health earlier by identifying risks, offering prevention tips, and referring to a specialist when needed.

And here’s something especially important for women going through menopause: Menopause is a natural time to start conversations about bone health—especially osteoporosis. The hormonal changes during menopause can accelerate bone loss, making it a critical moment to assess your risk and take proactive steps.

19/08/2025

Osteoporosis is often referred to as a silent disease meaning that many people learn they have the condition only after a fracture occurs.

At Organon, we’re committed to breaking the silence. With women at a higher risk of developing osteoporosis, we look to focus on critical elements:

- Fracture prevention
- Diagnosis before facture
- Bringing additional and potentially more affordable treatment options to doctors and their patients

15/08/2025

This summer isn’t just a season—it’s a reminder to prioritize your health. Take this time to see your doctor and make space for more honest conversations about your health.

From bone health to reproductive care, we’re committed to ensuring women have access to the information, support and treatment options they need to help improve their overall health.

14/08/2025

July was a month of inspiring initiatives across Organon. From Vietnam to Spain, our teams are making meaningful strides to help advance women's health around the world. Check them out:

📍Organon Italia Our CEO Kevin Ali visited Rome to meet with healthcare professionals, advocates, and policymakers to discuss two key priorities: addressing the impact of —especially on women—and exploring demographic resilience as an opportunity for innovation and stronger communities. He also participated in the event “Declining Birth Rates and the Sustainability of the Welfare System,” which featured the participation of experts, clinicians, and institutional leaders.

📍Organon Northwest Europe welcomed 278 new colleagues following the acquisition of the MSD Biotech production site in Oss, Netherlands, furthering Organon’s long-established presence in the Netherlands. This plant manufactures drug substances for two of our products, ensuring the consistent production and supply of these medicines for patients on their family planning journey.

📍Organon Asia Pacific Organon Vietnam has signed a Memorandum of Understanding with Long Châu to launch a nationwide initiative advancing women’s reproductive healthcare. This partnership combines Organon’s global expertise with Long Châu’s pharmacy network to enhance counselling quality, expand access to community-based care and education, and coordinate efforts to ensure regulatory compliance and program quality.

📍Organon ANZ announced that our post-partum hemorrhage treatment is now included on the Australian Register of Therapeutic Goods (ARTG).

📍Organon Brasil The inclusion of one of our longer-acting contraceptive products in Brazil’s Unified Health System, available free of charge to women at Basic Health Units, represents an important advancement for public health in Brazil by expanding access to longer-acting contraceptive options.

📍Organon Spain launched with other companies, Carmen, an alliance that brings together companies, universities, and foundations to work together to help reduce the inequalities that affect women’s health. It also aims to raise awareness on the disparities in research, investment, habits, and healthcare that impact women.

🌎

07/08/2025

There are a variety of birth control options available, including shorter and longer-term options. For some women, long-acting reversible contraception (LARCs), which can be used for multiple years, may be the option that most aligns with their reproductive goals.

As women consider the contraceptive that’s right for them, working with a healthcare professional is key to making informed decisions.

Intended for US audiences only.

05/08/2025

According to a survey by KFF in 2020, 50% of women ages 26-35 see an OB/GYN for check-ups or well-woman visits. From screening for osteoporosis to finding ways to manage and cope with stress, hear from board-certified OB/GYN Dr. Christine Greves on why these visits matter when it comes to supporting the whole health of a woman.

31/07/2025

Osteoporosis is often a silent disease because people may not know they have it until a fracture occurs.

More than 200 million people live with osteoporosis worldwide, yet many are undiagnosed and untreated. Women are at higher risk of developing it, especially later in life due to menopause, which predisposes them to bone loss as estrogen levels decline.

At Organon, we’re committed to addressing health conditions that impact women uniquely, disproportionately and differently.

We’re building on our bone health legacy to expand access to affordable treatments as well as supporting earlier diagnosis and better care worldwide, particularly for osteoporosis which is often overlooked.

30/07/2025

This year marked our very first time at the National Eczema Association Eczema Expo—and wow, what an unforgettable experience! 💙 From the moment we arrived, we were moved by the energy and passion of the community.

✨ Expo Highlight ✨
📸 Our booth included The Polaroid Project—an interactive space where attendees captured their favorite part of the expo.

The reflections shared and heartfelt stories left us feeling incredibly inspired and more committed to supporting this community of patients, caregivers, and healthcare professionals.

Address

30 Hudson Street

07302

Website

http://www.organon.com/

Alerts

Be the first to know and let us send you an email when Organon posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Organon:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City: